N. Chilingirova

Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth

Lazar Popovic, A. Valachis, K. Kamposioras, 2020, Frontiers in Oncology.

Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer

Z. Horváth, M. Dank, B. Pikó, 2022, Pathology & Oncology Research.

Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach

F. Alongi, S. Corradini, A. Valachis, 2022, Oncology Research and Treatment.

Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic

F. Alongi, S. Corradini, C. Salembier, 2020, The Lancet Oncology.

TruSight Cancer Sequencing Panel reveals pharmacogenetic variants associated with sensitivity to chemotherapy in lung cancer

D. Toncheva, R. Vazharova, S. Ivanov, 2016, memo - Magazine of European Medical Oncology.

Pharmacokinetic profile and safety of intravenous NEPA, a fixed combination of fosnetupitant and palonosetron, in cancer patients: Prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy.

V. Stella, A. Bernareggi, G. Kurteva, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.